Dosage form: extended-release capsules
Drug classes:Glucocorticoids, Inhaled corticosteroids
Medically reviewed by Drugs.com. Last updated on Dec 22, 2021.
On This Page
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Drug Interactions
- Use In Specific Populations
- Overdosage
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- Clinical Studies
- References
- How Supplied/Storage and Handling
- Patient Counseling Information
Indications and Usage for Budesonide Capsule
Treatment of Mild to Moderate Active Crohn's Disease
ORTIKOS is indicated for the treatment of mild to moderate active Crohn's disease involving the ileum and/or the ascending colon in patients 8 years of age and older.
Maintenance of Clinical Remission of Mild to Moderate Crohn's Disease
ORTIKOS is indicated for the maintenance of clinical remission of mild to moderate Crohn’s disease involving the ileum and/or the ascending colon for up to 3 months in adults.
Budesonide Capsule Dosage and Administration
Administration Instructions
- Take ORTIKOS once daily in ...
